Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SANOFI CONSUMER HEALTHCARE INDIA LTD.

NSE : SANOFICONRBSE : 544250ISIN CODE : INE0UOS01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE4299.6565.35 (+1.54 %)

PREV CLOSE ( ) 4234.30

OPEN PRICE ( ) 4250.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 92

TODAY'S LOW / HIGH ( )4166.40 4378.40

52 WK LOW / HIGH ( )3967 5954

NSE4290.4068.9 (+1.63 %)

PREV CLOSE( ) 4221.50

OPEN PRICE ( ) 4221.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 23192

TODAY'S LOW / HIGH( ) 4171.80 4389.00

52 WK LOW / HIGH ( )3990 5894.5

Select year

(Rs.in Million)

Particulars

Dec 2024

Dec 2023

Profit Before Tax

2468.00

2193.00

Adjustment

5.00

-22.00

Changes In working Capital

3161.00

-2133.00

Cash Flow after changes in Working Capital

5634.00

38.00

Cash Flow from Operating Activities

4390.00

-4.00

Cash Flow from Investing Activities

19.00

Cash Flow from Financing Activities

-1156.00

20.00

Net Cash Inflow / Outflow

3253.00

16.00

Opening Cash & Cash Equivalents

16.00

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

3269.00

16.00